Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02038959 · ClinicalTrials.gov registry record · NA

Connect.Parkinson: Connecting Individuals With Parkinson Disease to Specialists in Their Homes

A NA study, sponsored by University of Rochester.

Completed
Registry status
NA
Development phase
210
Enrollment target

NCT02038959 is a NA study that has completed, run by University of Rochester. The registered enrollment target is 210 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02038959, a NA study, has completed, sponsored by University of Rochester.

COMPLETED
Registry status
NA
Development phase
210 participants
Enrollment target

Study Summary

Connect.Parkinson is a randomized comparative effectiveness study, comparing usual care enhanced with educational materials to usual care, educational materials, and the delivery of specialty care via telemedicine into patient's homes. The study's specific aims are the following: 1. To demonstrate the feasibility of using telemedicine to deliver specialty care into the homes of individuals with Parkinson disease who have limited access to care; 2. To show that such an approach can improve quality of life; 3. To establish that the telemedicine can enhance the quality of care; and 4. To demonstrate that this remote approach to care saves time, reduces travel, and decreases care partner burden.

Interventions

  • OTHER Virtual Visits

Trial Details

FieldValue
Enrollment Target 210 participants
Start Date 2014-03
Est. Completion 2016-08
Phase NA

Sponsor

University of Rochester

636 total trials

What the Registry Record Tells You About NCT02038959

The ClinicalTrials.gov registry entry for NCT02038959 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 210 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Rochester, which has 636 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Virtual Visits is the first listed.

NCT02038959 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT02038959 about?

NCT02038959 is a clinical study titled "Connect.Parkinson: Connecting Individuals With Parkinson Disease to Specialists in Their Homes". Connect.Parkinson is a randomized comparative effectiveness study, comparing usual care enhanced with educational materials to usual care, educational materials, and the delivery of specialty care via telemedicine into patient's homes. The study's specific aims are the following: 1. To demonstrate ...

What is the current status of trial NCT02038959?

This trial is currently completed. It is a NA study. The enrollment target is 210 participants. The study started on 2014-03. Estimated completion is 2016-08.

What interventions are being tested in trial NCT02038959?

The interventions under investigation include: Virtual Visits (OTHER).

Who is sponsoring clinical trial NCT02038959?

This trial is sponsored by University of Rochester, which has 636 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.